Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Research Institute for Clinical Oncology

Saitama Cancer Center

Saitama

Japan

Name/email consistency: high

Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan. 2005 - 2009
Saitama Cancer Center Research Institute, 818 Komuro, Ina, Kita-adachi, 362-0806, Japan. 2002 - 2003
Saitama Cancer Center Research Institute, Japan. 2002

Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells. Okabe-Kado, J., Kasukabe, T., Honma, Y., Kobayashi, H., Maseki, N., Kaneko, Y. Cancer Sci. (2009) [Pubmed]
Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production. Okabe-Kado, J., Kasukabe, T., Honma, Y., Kobayashi, H., Maseki, N., Kaneko, Y. Int. J. Hematol. (2009) [Pubmed]
Clinical significance of serum NM23-H1 protein in neuroblastoma. Okabe-Kado, J., Kasukabe, T., Honma, Y., Hanada, R., Nakagawara, A., Kaneko, Y. Cancer Sci. (2005) [Pubmed]
Physiological and pathological relevance of extracellular NM23/NDP kinases. Okabe-Kado, J., Kasukabe, T. J. Bioenerg. Biomembr. (2003) [Pubmed]
Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages. Okabe-Kado, J., Kasukabe, T., Honma, Y. Leuk. Res. (2002) [Pubmed]
Serum nm23-H1 protein as a prognostic factor in hematological malignancies. Okabe-Kado, J. Leuk. Lymphoma (2002) [Pubmed]